Exenatide extended release and Factor XIII A-Subunit (Recombinant)
Determining the interaction of Exenatide extended release and Factor XIII A-Subunit (Recombinant) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: exenatide
Brand name: Byetta Prefilled Pen, Bydureon, Bydureon BCise, Bydureon Pen, Bydureon Tray
Synonyms: Exenatide
Generic Name: factor XIII
Brand name: Corifact, Tretten
Synonyms: Factor XIII
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Exenatide extended release-Factor XIII Concentrate (Human)
- Exenatide extended release-Factor xiii Intravenous
- Exenatide extended release-Factrel
- Exenatide extended release-FaLessa
- Exenatide extended release-FaLessa Kit
- Exenatide extended release-Fallback Solo
- Factor XIII A-Subunit (Recombinant)-Exenatide Extended-Release Injection (Bydureon BCise)
- Factor XIII A-Subunit (Recombinant)-Exenatide Extended-Release Injection (Bydureon) (Pens)
- Factor XIII A-Subunit (Recombinant)-Exenatide Extended-Release Injection (Bydureon) (Trays)
- Factor XIII A-Subunit (Recombinant)-Exenatide Injection (Byetta)
- Factor XIII A-Subunit (Recombinant)-Exenatide Subcutaneous
- Factor XIII A-Subunit (Recombinant)-Exfoliating Moisturizer